Its common with small biotech's when they reach a certain inflection point (an expected major announcement, like this distributor deal) in their progress to have a delay in the movement of the SP. It's due to hesitation of the market from previous delays and mis-steps.
The FDA approval or sales announcement by the distributor may trigger the interest and hence the rerate.
LBT chart, page-7
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.002(9.38%) |
Mkt cap ! $23.47M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.5¢ | $38.2K | 2.526M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1719439 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 1133000 | 4 |
View Market Depth
| Last trade - 14.29pm 19/08/2024 (20 minute delay) ? |
| LBT (ASX) Chart |